Search tool

Prevalence of problem drug use (PDU) is one of five key indicators used by the EMCDDA to provide more comparable, scientifically based estimates of the prevalence of more severe patterns of drug...

This publication was drawn up by the steering group created by the EMCDDA's Scientific Committee in November 1998 to establish guidelines to assess the risks of all new synthetic drugs identified under...

Prevalence of problem drug use (PDU) is one of five key indicators used by the EMCDDA to provide more comparable, scientifically based estimates of the prevalence of more severe patterns of drug...

This is the final report of a feasibility study on proposals to improve the quality and comparability of data on drug-related (DRD) deaths. The study, co-ordinated by the Trimbos Institute in the...

This is the final report of the EMCDDA project 'Review of scientific studies of mortality among drug users and feasibility study for a common methodology for monitoring overall and cause-specific mortality among...

This report presents the findings from an EMCDDA-funded methodological pilot study of local level prevalence estimates. Following on from a joint EMCDDA/Pompidou Group meeting, comparative pilot studies to improve the prevalence estimation...

Treatment monitoring systems are one of the information sources in the field of drug epidemiology and demand reduction, which can give valuable information on the scale and characteristics of the drugs phenomenon...

This is a landmark publication on prevalence estimation theory and method in the European Union. The monograph – the result of collaboration between 30 scientific authors – explores the relationship between epidemiological...